Stefan Loren

Stefan D.
Loren is the founder of Loren Capital Strategy LLC, founded in 2014.
Current jobs include Managing Director at Oppenheimer & Co., Inc. since 2017 and serving on the Advisory Board of Prevail Partners LLC.
Former jobs include Managing Director-Healthcare Group at Legg Mason, Inc. from 1997 to 2005; Board Director at GenVec, Inc. from 2013 to 2017; Director at Orchid Cellmark, Inc.; Director at PolyMedix, Inc. from 2008 to 2011; Managing Director at Legg Mason Wood Walker, Inc. in 2005; Alumni Board Director at the University of California San Diego from 2010 to 2015; Lead Independent Director at Adhera Therapeutics, Inc. from 2012 to 2017; Managing Director at Westwicke Partners LLC from 2008 to 2014; Independent Director at Cellectar Biosciences, Inc. from 2015 to 2026; Research Chemist-Advanced Technologies Division at Abbott Laboratories; Board Member at Orchid Cellmark, Inc. from 2010 to 2011; Analyst at Perceptive Advisors LLC from 2007 to 2008; Board at Adhera Therapeutics, Inc.; Advisor at Numoda Capital Innovations LLC; and Portfolio Manager at MTB Investment Advisors, Inc. Education includes a doctorate from the University of California, Berkeley in 1992 and an undergraduate degree from the University of California San Diego in 1987.